Drug Buyers' $62M Generic-Pricing Deal Gets Final OK
A federal judge granted final approval to wholesalers on settlements worth a total of at least $62 million with Glenmark Pharmaceutical Inc., Pfizer Inc. and Pfizer subsidiary Greenstone LLC over claims...To view the full article, register now.
Already a subscriber? Click here to view full article